Use of recombinant B-cell differentiation factor for augmenting antibody production and stimulating bone marrow proliferation
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 8, 1994
Issued Date -
N/A
app pub date -
May 4, 1992
filing date -
Aug 6, 1986
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
A purified human B-cell differentiation factor (BCDF) which does not have a natural signal peptide attached to the N-terminal thereof, DNA encoding the BCDF, transformed cells containing such DNA, a process for producing and obtaining the BCDF, compositions containing the BCDF and various therapeutic uses are disclosed.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully